Electric Literature of 108229-82-9, Chemistry is the experimental science by definition. We want to make observations to prove hypothesis. For this purpose, we perform experiments in the lab. 108229-82-9, Name is 6-Bromo-2,3-dichloroquinoxaline,introducing its new discovery.
METHOD OF TREATING GLYCOGEN STORAGE DISEASE
The present disclosure provides methods and compositions for the treatment of hepatic symptoms of glycogen storage diseases through the administration of thyroid hormone receptor agonists. The methods and compositions provided herein are useful in the treatment of hyperlipidemia, hypercholesterolemia, hepatic steatosis, cardiomegaly, hepatomegaly, hepatic fibrosis, and cirrhosis associated with glycogen storage diseases (GSD) and defects of glycogen metabolism. Said compounds may also be useful in the prevention of GSD-related hepatocellular adenoma and hepatocellular carcinoma.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 108229-82-9, and how the biochemistry of the body works.Electric Literature of 108229-82-9
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1998 | ChemSpider